No Data
No Data
GH Research Initiated at Overweight by Cantor Fitzgerald
GH Research Analyst Ratings
Cantor Fitzgerald Initiates GH Research(GHRS.US) With Buy Rating, Announces Target Price $14
Atai CEO Rao Optimistic About Psychedelic Therapies Despite Lykos Setback
GH Research PLC's (NASDAQ:GHRS) Top Key Executive Florian Schonharting Is the Most Upbeat Insider, and Their Holdings Increased by 31% Last Week
Rodman & Renshaw Maintains GH Research(GHRS.US) With Buy Rating, Cuts Target Price to $36